GrowingStockReport.com

NASDAQ Active Stock Watch List: ViroPharma Inc. (NASDAQ:VPHM) and ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Added to Growing Stock Report's NASDAQ Active Stock Watch List.

 
Repost This

New York, NY -- (SBWIRE) -- 12/03/2013 -- Growing Stock Report expands its NASDAQ Active Stock Watch List adding ViroPharma Inc. (NASDAQ:VPHM) and ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD).

ViroPharma Inc. (NASDAQ:VPHM) a biotechnology company that develops and commercializes therapeutic products that address serious diseases in the United States and internationally closed down in its previous session (-0.02%) on 3,799,436 shares traded. ViroPharma Inc. (NASDAQ:VPHM) is currently down (-0.44%) from its recent 52-week high which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about ViroPharma Inc. (NASDAQ:VPHM)

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) a biopharmaceutical company that focuses on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders closed up in its previous session (+7.34%) on 2,531,201 shares traded. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is currently up (+504.32%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Active Stock Watch List.

Click Here to find out what other Investors are saying about ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.

Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.

Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.GrowingStockReport.com

Disclosure
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.

Contact Info:
Growing Stock Report
editor@GrowingStockReport.com